Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis
AustriaStudy of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis
FranceStudy on the Effectiveness and Safety of Oral Midazolam for Elderly Patients with Severe Neurocognitive Disorders and Care Resistance
FranceStudy on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)
SwedenStudy on the Safety and Long-Term Effects of Efavirenz for Adults and Late-Onset Juvenile Niemann-Pick Type C Disease with Cognitive Impairment
SpainStudy of Atidarsagene Autotemcel for Treating Early Onset Metachromatic Leukodystrophy (MLD) in Patients
ItalyStudy on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson's Disease Patients with Motor Fluctuations
AustriaStudy on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease
AustriaStudy on Selumetinib for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
FranceStudy of Nacystelyn for Patients with Obstructive Sleep Apnea
BelgiumStudy of brivaracetam as a treatment for childhood and juvenile absence epilepsy in patients aged 2-25 years
ItalyStudy on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy
FranceThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
